Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Idris

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Molecular Cancer Therapeutics|August 13, 2009
Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivoAymen I Idris, Hélène Libouban, Hervé Nyangoga, et al.
The Journal of International Medical Research|April 11, 2025
White spot lesion in self-ligating versus conventional ligating bracket systems: A systematic reviewMohammad I Idris, Ahmad S Burhan, Mohammad Y Hajeer, et al.
Calcified Tissue International|February 9, 2008
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitroAymen I Idris, Javier Rojas, Iain R Greig, et al.
Calcified Tissue International|April 1, 2019
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex VivoSilvia Marino, Ryan T Bishop, Giovana Carrasco, et al.
The Journal of Biological Chemistry|July 22, 2015
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced OsteolysisAntonia Sophocleous, Silvia Marino, John G Logan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 15, 2012
Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysisJohn G Logan, Antonia Sophocleous, Silvia Marino, et al.
Endocrinology|March 31, 2011
The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formationAntonia Sophocleous, Euphemie Landao-Bassonga, Robert J Van't Hof, et al.
Endocrinology|July 19, 2008
Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptorAymen I Idris, Antonia Sophocleous, Euphemie Landao-Bassonga, et al.
The Journal of Endocrinology|December 15, 2000
Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitroD Patiag, X Qu, S Gray, et al.
Calcified Tissue International|September 21, 2010
The biphenyl-carboxylate derivative ABD328 is a novel orally active antiresorptive agentAymen I Idris, Emmanuel Coste, Iain R Greig, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Molecular Cancer Therapeutics|August 13, 2009
Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivoAymen I Idris, Hélène Libouban, Hervé Nyangoga, et al.
The Journal of International Medical Research|April 11, 2025
White spot lesion in self-ligating versus conventional ligating bracket systems: A systematic reviewMohammad I Idris, Ahmad S Burhan, Mohammad Y Hajeer, et al.
Calcified Tissue International|February 9, 2008
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitroAymen I Idris, Javier Rojas, Iain R Greig, et al.
Calcified Tissue International|April 1, 2019
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex VivoSilvia Marino, Ryan T Bishop, Giovana Carrasco, et al.
The Journal of Biological Chemistry|July 22, 2015
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced OsteolysisAntonia Sophocleous, Silvia Marino, John G Logan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 15, 2012
Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysisJohn G Logan, Antonia Sophocleous, Silvia Marino, et al.
Endocrinology|March 31, 2011
The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formationAntonia Sophocleous, Euphemie Landao-Bassonga, Robert J Van't Hof, et al.
Endocrinology|July 19, 2008
Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptorAymen I Idris, Antonia Sophocleous, Euphemie Landao-Bassonga, et al.
The Journal of Endocrinology|December 15, 2000
Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitroD Patiag, X Qu, S Gray, et al.
Calcified Tissue International|September 21, 2010
The biphenyl-carboxylate derivative ABD328 is a novel orally active antiresorptive agentAymen I Idris, Emmanuel Coste, Iain R Greig, et al.
Pageof 12